(Total Views: 254)
Posted On: 10/30/2018 8:47:38 AM
Post# of 106589
KALY She's a bad Momma!
Possible merger with PURA?
Watch this go absolutely SICK Today!
Load all you can! $$$$$$$$$$
Kali, Inc. (USOTC: KALY) today announced entering into discussions with Puration, Inc. (USOTC: PURA) and Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV) to explore forming a joint venture company between the three to develop cannabis pharmaceutical products. Kali recently announced a letter of intent to acquire NCM Biotech, the developer and owner of a patented cannabis extraction process - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT." Separately, Puration has licensed the NCM patent for use in specific commercial applications. Nouveau has recently acquired a cannabis cultivation operation from Puration. In the joint venture, Kali would build on NCM's medical research, and Puration's commercial experience, combined with Nouveau's plans to develop a proprietary pharmaceutical grade hemp cultivar, to together develop cannabis pharmaceutical products in partnerships with established pharmaceutical development companies.
Possible merger with PURA?
Watch this go absolutely SICK Today!
Load all you can! $$$$$$$$$$
Kali, Inc. (USOTC: KALY) today announced entering into discussions with Puration, Inc. (USOTC: PURA) and Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV) to explore forming a joint venture company between the three to develop cannabis pharmaceutical products. Kali recently announced a letter of intent to acquire NCM Biotech, the developer and owner of a patented cannabis extraction process - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT." Separately, Puration has licensed the NCM patent for use in specific commercial applications. Nouveau has recently acquired a cannabis cultivation operation from Puration. In the joint venture, Kali would build on NCM's medical research, and Puration's commercial experience, combined with Nouveau's plans to develop a proprietary pharmaceutical grade hemp cultivar, to together develop cannabis pharmaceutical products in partnerships with established pharmaceutical development companies.
(0)
(0)
